| Issue Date | Title | Author(s) |
| 15-Jul-2013 | [18F]-Flumazenil: A γ-aminobutyric acid A–specific PET radiotracer for the localisation of drug resistant temporal lobe epilepsy | Vivash, L; Grégoire, MC; Lau, EW; Ware, RE; Binns, D; Roselt, P; Bouilleret, V; Myers, DE; Cook, MJ; Hicks, RJ; O’Brien, TJ |
| 11-Oct-2010 | Development of [18F]-Flumazenil-PET for localisation of the epileptogenic zone in patients with medically refractory focal epilepsy | Vivash, L; Grégoire, MC; Dedeurwaerdere, S; Bouilleret, V; Roselt, P; Lau, EW; Ware, RE; Binns, D; Katsifis, A; Hicks, RJ; Myers, DE; O'Brien, TJ |
| 10-Sep-2009 | Discovery of [F-18]N-(2-(Diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance | Greguric, I; Taylor, SR; Denoyer, D; Ballantyne, P; Berghofer, PJ; Roselt, P; Pham, TQ; Mattner, F; Bourdier, T; Neels, OC; Dorow, DS; Loc'h, C; Hicks, RJ; Katsifis, A |
| 1-Jul-2011 | Fully automated one-pot radiosynthesis of O-(2-[18F]fluoroethyl)-L-tyrosine on the TracerLab FXFN module | Bourdier, T; Greguric, I; Roselt, P; Jackson, TW; Faragalla, J; Katsifis, A |
| Mar-2010 | High-contrast PET of melanoma using F-18-MEL050, a selective probe for melanin with predominantly renal clearance | Denoyer, D; Greguric, I; Roselt, P; Neels, OC; Aide, N; Taylor, SR; Katsifis, A; Dorow, DS; Hicks, RJ |
| 14-Jun-2007 | Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA – first small animal PET results | Reischl, G; Dorow, D; Cullinane, C; Katsifis, A; Roselt, P; Binns, D; Hicks, RJ |
| 1-Jan-2011 | Improved detection of regional melanoma metastasis using 18F-6-Fluoro-N-[2-(Diethylamino)Ethyl] Pyridine-3-Carboxamide, a Melanin-specific PET probe, by perilesional administration | Denoyer, D; Potdevin, T; Roselt, P; Neels, OC; Kirby, L; Greguric, I; Katsifis, A; Dorow, DS; Hicks, RJ |
| 21-Jan-2014 | In vivo measurement of hippocampal GABAA/cBZR density with [18F]-Flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy | Vivash, L; Grégoire, MC; Bouilleret, V; Berard, A; Wimberley, CA; Binns, D; Roselt, P; Katsifis, A; Myers, DE; Hicks, RJ; O'Brien, TJ; Dedeurwaerdere, S |
| Jun-2009 | In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat | Dedeurwaerdere, S; Grégoire, MC; Vivash, L; Roselt, P; Binns, D; Fookes, CJR; Greguric, I; Pham, TQ; Loc'h, C; Katsifis, A; Hicks, RJ; O'Brien, TJ; Myers, DE |
| 1-Apr-2012 | Preclinical characterization of 18FD-FPHCys, a new amino acid-based PET tracer | Denoyer, D; Kirby, L; Waldeck, K; Roselt, P; Neels, OC; Bourdier, T; Shepherd, R; Katsifis, A; Hicks, RJ |
| 1-Jan-2011 | Radiosynthesis of a novel PET fluoronicotinamide for melanoma tumour PET imaging [18F]MEL050 | Greguric, I; Taylor, S; Pham, TQ; Wyatt, NA; Jiang, CD; Bourdier, T; Loc'h, C; Roselt, P; Neels, OC; Katsifis, A |
| 18-Feb-2012 | Synthesis and radiosynthesis of a novel PET fluorobenzyl piperazine for melanoma tumour imaging; [18F]MEL054 | Taylor, SR; Roberts, MR; Wyatt, NA; Pham, TQ; Stark, D; Bourdier, T; Roselt, P; Katsifis, A; Greguric, I |
